The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm.
Name:
Vestergaard et al_final.pdf
Size:
365.2Kb
Format:
PDF
Description:
original manuscript
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2013-09
Metadata
Show full item recordCitation
The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm. 2013, 21 (9):1644-8 Mol. Ther.Affiliation
Danish Health and Medicines Authority, Copenhagen, Denmark.PubMed ID
24137820Type
ArticleLanguage
enISSN
1525-0024The following license files are associated with this item:
Related articles
- [Report from the Committee for Advanced Therapies (CAT). Pitfalls on the way from concept to medical treatment with advanced therapy medicinal products].
- Authors: Reiss M, Büttel IC, Schneider CK
- Issue date: 2011 Jul
- CAT--the new committee for advanced therapies at the European Medicines Agency.
- Authors: Celis P
- Issue date: 2010 Jan
- [Clinical trials with advanced therapy medicinal products].
- Authors: Schüssler-Lenz M, Schneider CK
- Issue date: 2010 Jan
- [Regulation (EC) No. 1394/2007 on advanced therapy medicinal products : Incorporation into national law].
- Authors: Dwenger A, Strassburger J, Schwerdtfeger W
- Issue date: 2010 Jan
- Exploring Solutions to Foster ATMP Development and Access to Patients in Europe.
- Authors: Salvatore V
- Issue date: 2020 May 28